XML 47 R37.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurements - Summary of Changes in Fair Value of the Level 3 Liabilities Related to the Roche Agreement (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2022
USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Derivative, Gain (Loss) on Derivative, Net
FairValue Measurements Recurring Member | Level 3 [Member]  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Balance at December 31, 2021 $ 6,450
Change in fair value of derivative liability (100)
Balance at December 31, 2022 $ 6,350